Class Action Lawsuit Filed Against Cedars-Sinai Over CT Radiation Overdose
One of the 206 patients who received a radiation overdose eight times normal during a CT scan at Cedars-Sinai Medical Center, has filed a class action lawsuit against both the hospital and the device manufacturer, GE Healthcare Technologies.
The lawsuit alleges that the plaintiff, Trevor Rees, was not only subjected to an overdose of radiation, but faces a higher risk of cancer, expense of longer term health monitoring of its effects, and suffers "severe and serious physical and emotional damage." Rees actually underwent two scans, and potentially received the overdose twice.
The lawsuit also maintains that hospital officials who contacted Rees nine months later asked about whether he had experienced side effects, but did not tell him he had been overexposed.
"There was no mention of radiation to me on the phone at all," Rees said in a statement issued by his Los Angeles attorney, William Newkirk. "I never thought anything more about it until I saw the news about five days later."
The 19-page complaint, filed on behalf of Rees and Does 1-100, seeks to represent "all individuals who received CT brain perfusion scans at CSMC from February, 2008 until August, 2009, or at any other medical or imaging facilities utilizing CT imaging machines manufactured by GEHC/GEHCT, during the two-year period preceding this action." It was filed in Los Angeles Superior Court.
Newkirk said yesterday in a statement, "This isn't just a Cedars-Sinai problem. We believe that because of the way the machine is manufactured and explained to medical users, there is a very good chance that this same situation has been or is being played out in radiology departments across the country. We have no idea how many people have been overdosed with radiation."
It is not known whether other hospitals or healthcare facilities using the same GE scanners, identified as 64-slice CT machines, experienced overdoses of radiation. But the U.S. Food and Drug Administration said that it was launching a safety investigation that extended beyond Cedars-Sinai.
"While this event involved a single kind of diagnostic test at one facility, the magnitude of these overdoses and their impact on the affected patients were significant," the FDA said Oct. 8 in an initial notification notice. "This situation may reflect more widespread problems with CT quality assurance programs and may not be isolated to this particular facility or this imaging procedure (CT brain perfusion)."
In a statement, a GE Healthcare spokesman yesterday said the company is "aware of litigation regarding the incident at Cedars-Sinai" but is unable to comment on specifics.
"We remain concerned for the health of patients who may have received excess medical radiation at Cedars-Sinai Medical Center. GE Healthcare continues to cooperate with the Food and Drug Administration officials on this matter. Although GE Healthcare continues its internal investigation, we confirm that there were no malfunctions or defects in any of the GE Healthcare equipment involved."
GE's statement adds: "GE Healthcare continues to offer dose-reducing technologies and expand key CT training initiatives to raise awareness of dose optimization and use of appropriate exam protocols.
"GE Healthcare CT products require that:
"1) Users carefully evaluate user-defined scanning protocols against the validated protocols that are provided on the scanners during installation, and
"2) Like dose recommendations for drugs, the recommended dose for a prescribed medical imaging scan is an important clinical decision that should be made by a licensed professional in the context of healthcare delivery.
- CMS to Speak with ICD-10 Backers Tuesday
- Boston Marathon Bombing Yields Lessons for Hospitals
- Governor Details Healthcare Payment Reform Path in Arkansas
- Reform Puts Vise Grips on Physicians
- Hospital Groups Back NQF Report on Patient Sociodemographics
- MetroHealth Revs Its Population Health Engine
- Medicare Opt-Out a Viable Physician Strategy
- Providers Lag as Consumers Set Agenda
- NPP Demand Rising Under Value-Based Care Models
- HIX Success Could Generate Add-On Revenue for CT